Is EBV the cause of multiple sclerosis?

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

(2022) Kjetil Bjornevik et al.   SCIENCE

High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk

(2020) Anna Karin Hedström et al.   Frontiers in Neurology

Vaccination against the Epstein–Barr virus

(2020) Julia Rühl et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence

(2020) Deniz Bakkalci et al.   Journal of Global Health

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

(2020) C. L. Kemmerer et al.   PLoS One

Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

(2020) Hana Zdimerova et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Progress in EBV Vaccines

(2019) Dwain G. van Zyl et al.   Frontiers in Oncology

A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis

(2019)   Nature Communications

Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis

(2019) D. Baker et al.   EUROPEAN JOURNAL OF NEUROLOGY

OUP accepted manuscript

(2018)   BRAIN

Lifestyle and Environmental Factors in Multiple Sclerosis

(2018) Lars Alfredsson et al.   Cold Spring Harbor Perspectives in Medicine

The neurodegenerative prodrome in multiple sclerosis

(2017) Gavin Giovannoni   LANCET NEUROLOGY

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

(2017) David Baker et al.   EBioMedicine

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

(2016) Peter Alping et al.   ANNALS OF NEUROLOGY

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

(2016) Tomas Olsson et al.   Nature Reviews Neurology

Viruses as potential pathogenic agents in systemic lupus erythematosus

(2014) P Nelson et al.   LUPUS

Epstein–Barr virus and multiple sclerosis: association or causation?

(2013) Julia Pakpoor et al.   Expert Review of Neurotherapeutics

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

(2012) J. Pakpoor et al.   Multiple Sclerosis Journal

Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

(2011) KL Munger et al.   Multiple Sclerosis Journal

The diagnostic criteria for multiple sclerosis: From Charcot to McDonald

(2011) Arie Gafson et al.   Multiple Sclerosis and Related Disorders

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

(2010) Sreeram V Ramagopalan et al.   LANCET NEUROLOGY

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis

(2010) Adam E. Handel et al.   PLoS One